You are here: Industry Insights > kidney

News List

osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer PharmaSources
January 19, 2023
So far osteolabs has successfully applied its proprietary Calcium Isotope Marker Technology for the early detection and therapy monitoring in the field of osteoporosis.
Need for Speed: Kidney cancer patients waiting three times longer pharmatimes
February 08, 2022
Need for Speed: Kidney cancer patients waiting three times longer.
Acute Kidney Injury Hospitalization-Linked Mortality Is High drugs.com
February 07, 2022
Mortality associated with acute kidney injury (AKI) hospitalization is high, with 28 percent dying within one year, according to a study published...
Timely intervention: First chronic kidney disease treatment in 20 years pharmatimes
February 03, 2022
Significant landmark as NICE recommends AstraZeneca's chronic kidney disease treatment Forxiga.
Merck’s Keytruda obtains EC approval as adjuvant therapy for kidney cancer Pharmaceutical-Technology
January 28, 2022
In a Phase III trial, Keytruda lowered the disease recurrence or mortality risk by 32% versus placebo.
Common Gout Drug Allopurinol Is Safe in Patients With Kidney Issues By Alan Mozes HealthDay Reporter drugs.com
January 26, 2022
Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle...
ProKidney signs SPAC merger deal with Social Capital Suvretta Pharmaceutical-Technology
January 20, 2022
ProKidney delivers disease-altering autologous cell therapy to treat chronic kidney disease.
Heterogeneity Identified in Global Kidney Nutrition Care drugs
January 11, 2022
There is considerable heterogeneity in global kidney nutrition care, according to a study published online Jan. 3 in the Clinical Journal of the American Society of Nephrology.
COVID-19 Can Cause Scarring of Kidneys: Study drugs
December 30, 2021
COVID-19 patients are at risk for serious long-term kidney damage, according to the results of a new investigation.
Positive CHMP opinion for finerenone as new treatment for chronic kidney disease and type 2 diabetes pharmatimes
December 20, 2021
It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.